Francesc Coll
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
- Antimicrobial Resistance in Staphylococcus
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 24
- Antimicrobial Resistance in Staphylococcus 23
- SARS-CoV-2 and COVID-19 Research 9
- Infection Control in Healthcare 5
-
- Antibiotic Resistance in Bacteria 6
- Co-authors
- Taane Gregory Clark (19 shared papers)Ruth McNerney (17 shared papers)Julian Parkhill (26 shared papers)Arnab Pain (13 shared papers)José Afonso Guerra‐Assunção (6 shared papers)Judith R. Glynn (5 shared papers)Sharon J. Peacock (25 shared papers)João Perdigão (4 shared papers)
- Journals
- Nature Communications (6 papers)The Lancet Microbe (5 papers)Microbial Genomics (4 papers)Genome Medicine (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- United KingdomSaudi ArabiaUnited States
In The Last Decade
Francesc Coll
69 papers receiving 6.8k citations
Francesc Coll's Hit Papers
Peers
Comparison fields: 5 of 129
- Infectious Diseases 5.5k
- Molecular Medicine 468
- Applied Microbiology and Biotechnology 142
- Modeling and Simulation 236
- Endocrinology 81
Countries citing papers authored by Francesc Coll
This map shows the geographic impact of Francesc Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesc Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesc Coll more than expected).
Fields of papers citing papers by Francesc Coll
This network shows the impact of papers produced by Francesc Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesc Coll. The network helps show where Francesc Coll may publish in the future.
Co-authors
The 25 scholars most cited alongside Francesc Coll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 2 | 2020 | 756 | |
| 3 | Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study Hit paper breakdown → | 2021 | 592 |
| 4 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 5 | A robust SNP barcode for typing Mycobacterium tuberculosis complex strains Hit paper breakdown → | 2014 | 506 |
| 6 | Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences Hit paper breakdown → | 2015 | 325 |
| 7 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 325 |
| 8 | Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis Hit paper breakdown → | 2018 | 257 |
| 9 | 2021 | 228 | |
| 10 | 2015 | 205 | |
| 11 | The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis Hit paper breakdown → | 2022 | 194 |
| 12 | 2019 | 163 | |
| 13 | 2014 | 148 | |
| 14 | 2020 | 115 | |
| 15 | 2017 | 106 | |
| 16 | 2016 | 99 | |
| 17 | 2015 | 91 | |
| 18 | 2012 | 80 | |
| 19 | 2017 | 78 | |
| 20 | 2015 | 77 |
About Francesc Coll
Francesc Coll is a scholar working on Infectious Diseases, Molecular Medicine, Applied Microbiology and Biotechnology, Endocrinology and Modeling and Simulation, having authored 71 papers that have together received 6.9k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (24 papers), Antimicrobial Resistance in Staphylococcus (23 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Antibiotic Resistance in Bacteria (6 papers), Genomics and Phylogenetic Studies (5 papers), Infection Control in Healthcare (5 papers), Antibiotic Use and Resistance (3 papers) and Escherichia coli research studies (2 papers). The work is most often cited by research in Infectious Diseases (5.5k citations), Molecular Medicine (468 citations), Applied Microbiology and Biotechnology (142 citations), Modeling and Simulation (236 citations) and Endocrinology (81 citations). Francesc Coll has collaborated with scholars based in United Kingdom, Saudi Arabia and United States. Frequent co-authors include Taane Gregory Clark, Ruth McNerney, Julian Parkhill, Arnab Pain, José Afonso Guerra‐Assunção, Judith R. Glynn, Sharon J. Peacock, João Perdigão, Isabel Portugal and Miguel Viveiros. Their work appears in journals such as Nature Communications, The Lancet Microbe, Microbial Genomics, Genome Medicine and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.